Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
Gianluigi Savarese, Hong Xu, Marco Trevisan, et al.
JACC Heart Failure (2018) Vol. 7, Iss. 1, pp. 65-76
Closed Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
European Heart Journal (2021) Vol. 42, Iss. 36, pp. 3599-3726
Open Access | Times Cited: 8803
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa McDonagh, Marco Metra, Marianna Adamo, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 1, pp. 4-131
Open Access | Times Cited: 1537
The hazardous threat of Bisphenol A: Toxicity, detection and remediation
Ayon Tarafdar, Ranjna Sirohi, Palanisamy Athiyaman Balakumaran, et al.
Journal of Hazardous Materials (2021) Vol. 423, pp. 127097-127097
Closed Access | Times Cited: 232
Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis
Gregory Livshits, Alexander Kalinkovich
Ageing Research Reviews (2019) Vol. 56, pp. 100980-100980
Closed Access | Times Cited: 174
Polypharmacy in Older Adults Hospitalized for Heart Failure
Ozan Ünlü, Emily B. Levitan, Evgeniya Reshetnyak, et al.
Circulation Heart Failure (2020) Vol. 13, Iss. 11
Open Access | Times Cited: 142
Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden)
Gianluigi Savarese, Johan Bodegård, Anna Norhammar, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 9, pp. 1499-1511
Open Access | Times Cited: 139
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
Revista Española de Cardiología (2022) Vol. 75, Iss. 6, pp. 523.e1-523.e114
Closed Access | Times Cited: 89
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC
Gianluigi Savarese, Felix Lindberg, Antonio Cannatà, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1278-1297
Open Access | Times Cited: 17
Abnormalities of Potassium in Heart Failure
João Pedro Ferreira, Javed Butler, Patrick Rossignol, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 22, pp. 2836-2850
Open Access | Times Cited: 127
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA‐EORP Heart Failure Long‐Term Registry
Patrick Rossignol, Mitja Lainščak, María G. Crespo‐Leiro, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 8, pp. 1378-1389
Open Access | Times Cited: 111
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
João Pedro Ferreira, Faı̈ez Zannad, Javed Butler, et al.
European Heart Journal (2022) Vol. 43, Iss. 31, pp. 2984-2993
Open Access | Times Cited: 62
The Stockholm CREAtinine Measurements (SCREAM) project: Fostering improvements in chronic kidney disease care
Juan Jesús Carrero, Carl Gustaf Elinder
Journal of Internal Medicine (2022) Vol. 291, Iss. 3, pp. 254-268
Open Access | Times Cited: 54
Use of guideline‐recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence
Roemer J. Janse, Edouard L. Fu, Ulf Dahlström, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 11, pp. 2185-2195
Open Access | Times Cited: 45
Physician perceptions, attitudes, and strategies towards implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice
Gianluigi Savarese, Felix Lindberg, Ruxandra Christodorescu, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1408-1418
Open Access | Times Cited: 12
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Takeshi Kitai, Shun Kohsaka, Takao Kato, et al.
Journal of Cardiac Failure (2025)
Closed Access | Times Cited: 1
Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan
Naoki Kashihara, Shun Kohsaka, Eiichiro Kanda, et al.
Kidney International Reports (2019) Vol. 4, Iss. 9, pp. 1248-1260
Open Access | Times Cited: 67
Serum potassium in the PARADIGM‐HF trial
João Pedro Ferreira, Ulrik M. Mogensen, Pardeep S. Jhund, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 11, pp. 2056-2064
Open Access | Times Cited: 49
Patient profiles in heart failure with reduced ejection fraction: Prevalence, characteristics, treatments and outcomes in a real‐world heart failure population
Francesca Musella, Giuseppe Rosano, Camilla Hage, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 8, pp. 1246-1253
Open Access | Times Cited: 14
The role of the kidney in acute and chronic heart failure
Gaetano Ruocco, Alberto Palazzuoli, Jozine M. ter Maaten
Heart Failure Reviews (2019) Vol. 25, Iss. 1, pp. 107-118
Open Access | Times Cited: 38
Association of Non-Cardiac Comorbidities with the Outcomes of Admitting Acute heart failure Patients Tripoli, Libya
Elham Elgdhafi, Rehab Jerbi, MOHAMED B. EL‐HARARI
(2025), pp. 34-40
Closed Access
Hyperkalemia Is an Underestimated Risk Factor in COPD
Jukka Maenpää, Isobel Anderson, Caroline A. Owen, et al.
International Journal of COPD (2025) Vol. Volume 20, pp. 723-734
Open Access
Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT
João Pedro Ferreira, Xavier Rosselló, Stuart J. Pocock, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 9, pp. 1615-1624
Open Access | Times Cited: 29
Interrelation between heart failure with preserved ejection fraction and renal impairment
Jennifer Joslin, Eirini Lioudaki, Emmanuel Androulakis
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 2
Open Access | Times Cited: 17
Translating evidence into practice: Managing electrolyte imbalances and iron deficiency in heart failure
Ryosuke Sato, Michael Koziolek, Stephan von Haehling
European Journal of Internal Medicine (2024)
Closed Access | Times Cited: 3
The impact of sodium-glucose co-transporter-2 inhibitors on serum sodium and potassium in patients with Heart Failure: a systematic review and meta-analysis
Reza Amani‐Beni, Bahar Darouei, Davood Shafie, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top